FIELD: medicine, pharmacy.
SUBSTANCE: invention represents a pharmaceutical tablet comprising a core and bound envelope wherein (a) core comprises solid particles of water-soluble dye dispersed in matrix, and (b) envelope comprises hellanic gum. Due to the presence of water-soluble dye in the tablet core it shows spotted shape that provides easy recognition of the tablet. The tablet is useful for peroral and intraoral administration.
EFFECT: improved and valuable properties of tablet.
30 cl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL DOSED FORMULATION FOR DELIVERY THROUGH MUCOSA | 2003 |
|
RU2285520C2 |
| NOVEL RAPIDLY ACTING PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS ELICITING ACTIVITY IN SEXUAL DYSFUNCTION AND CACAO POWDER AND THEIR USING | 2003 |
|
RU2312665C2 |
| BENZYLIDENEGUANIDINE DERIVATIVES AND THERAPEUTIC USE THEREOF FOR TREATMENT OF PROTEIN MISFOLDING RELATED DISEASES | 2014 |
|
RU2654910C2 |
| METHODS AND COMPOSITIONS FOR TREATING DRY EYE DISEASE AND OTHER EYE DISEASES | 2016 |
|
RU2691412C2 |
| PHARMACEUTICAL COMPOSITIONS | 2007 |
|
RU2445077C2 |
| IBAT INHIBITOR FOR TREATING HEPATIC DISORDERS | 2011 |
|
RU2591188C2 |
| TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES | 2004 |
|
RU2380093C2 |
| ALKYLTHIOPYRIMIDINES AS CRTH2 ANTAGONISTS | 2008 |
|
RU2491280C2 |
| PERORAL PHARMACEUTICAL MEDICINAL FORMS INCLUDING PROTON PUMP INHIBITOR AND ANTACID SUBSTANCE OR ALGINATE | 1996 |
|
RU2179453C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING S1P RECEPTOR MODULATOR | 2007 |
|
RU2487703C2 |
